Is XAR or JNJ a better dividend investment in 2026?

XAR currently yields 0.36% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between XAR and JNJ?

XAR has a forward dividend yield of 0.36% ($0.88/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 3.00 percentage points.

Home › Compare › XAR vs JNJ

XAR vs JNJ: Dividend Comparison 2026

XAR yields 0.36% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 XAR wins by $156.00 in total portfolio value

INVESTMENT

TIME HORIZON10 years

XAR

● Live price

0.36%

Share price

$242.24

Annual div

$0.88

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.2K

Annual income

$37.11

Full XAR calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — XAR vs JNJ

📍 XAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XAR	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XAR + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XAR pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XAR

Annual income on $10K today (after 15% tax)

$30.81/yr

After 10yr DRIP, annual income (after tax)

$31.54/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $672.07/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XAR + JNJ for your $10,000?

XAR: 50%JNJ: 50%

100% JNJ50/50100% XAR

Portfolio after 10yr

$20.1K

Annual income

$432.45/yr

Blended yield

2.15%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

XAR

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XAR buys

JNJ buys

No recent congressional trades found for XAR or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXARJNJ

Forward yield	0.36%	3.36% ✓
Annual dividend / share	$0.88	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$20.2K ✓	$20.0K
Annual income after 10y	$37.11	$827.78 ✓
Total dividends collected	$367.00 ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	ETF	Healthcare

Year-by-year: XAR vs JNJ ($10,000, DRIP)

Year	XAR Portfolio	XAR Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$10,736	$36.25	$10,676	$355.77	+$60.00 → XAR
2	$11,524	$36.37	$11,407	$389.39	+$117.00 → XAR
3	$12,367	$36.49	$12,198	$426.53	+$169.00 → XAR
4	$13,270	$36.59	$13,056	$467.62	+$214.00 → XAR
5	$14,235	$36.70	$13,987	$513.12	+$248.00 → XAR
6	$15,268	$36.79	$14,998	$563.56	+$270.00 → XAR
7	$16,374	$36.88	$16,098	$619.52	+$276.00 → XAR
8	$17,557	$36.96	$17,295	$681.69	+$262.00 → XAR
9	$18,823	$37.04	$18,599	$750.82	+$224.00 → XAR
10	$20,178	$37.11	$20,022	$827.78	+$156.00 → XAR

XAR vs JNJ: Complete Analysis 2026

XAR — ETF

The State Street SPDR S&P Aerospace & Defense ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Aerospace & Defense Select Industry Index (the "Index")Seeks to provide exposure to the Aerospace & Defense segment of the S&P TMI, which comprises the following sub-industries: Aerospace & DefenseSeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

Full XAR Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this XAR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XAR vs SCHD XAR vs JEPI XAR vs O XAR vs KO XAR vs MAIN XAR vs ABBV XAR vs MRK XAR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.